why choose us

First received: November 24, 2023

Clinical Trial: A Randomized Trial Evaluating a mRNA VLP Vaccine's Immunogenicity and Safety for COVID-19

Study Status: Completed

Recruit Status: RECRUITING

Condition: COVID-19

Study Type: INTERVENTIONAL


Official Title: A Phase I, Open-label, Randomized, Active-Controlled Study in Adults to Characterize the Safety and Immunogenicity of AZD9838 Vaccine (ARTEMIS-C)

Brief Summary: The purpose of this study is to characterize the safety and immunogenicity of AZD9838 when administered as a single dose vaccination against SARS-CoV-2 in adults.

Read more